Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load

Journal of Infection and Chemotherapy

Volumn 9, Issue 4, 2003, Pages 355-357

  Satoh, Masao ^a   Futami, Atsushi ^b   Takahira, Kenichiro ^b   Kodaira, Makoto ^b   Tanaka, Tokutaro ^b   Kuriki, Ken ^b   Hori, Eitaro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Yaizu City Hospital   (Japan)

Author keywords

HTLV 1; Hydrocephalus; Hypoalbuminemia; Meningitis; Proviral load; Strongyloidiasis

Indexed keywords

AMPICILLIN; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; LATAMOXEF; TIABENDAZOLE;

ADULT; ANTIBODY TITER; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; DISEASE SEVERITY; EDEMA; ENDEMIC DISEASE; HIGH RISK PATIENT; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; HYDROCEPHALUS; HYPOALBUMINEMIA; IMMUNITY; MALE; MENINGITIS; NONHUMAN; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION; VIRUS CARRIER; VIRUS LOAD;

EID: 0347363560     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0272-4     Document Type: Article

References (16)

1. Grove DI. Human strongyloidiasis. Adv Parasitol 1996;38:251-309.
2. Patey O, Gessain A, Breuil J, Courillon-Mallet A, Daniel MT, Miclea JM, et al. Seven years of recurrent severe strongyloidiasis in an HTLV-I infected man who developed adult T-cell leukaemia. AIDS 1992;6:575-9.
3. Satoh M, Tsukidate S, Fujita K, Yamamoto K. Strongyloidiasis influences the elevation of adult T-cell leukemia-associated antigen antibody titer. Int Arch Allergy Appl Immunol 1991;96:95-6.
4. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982;79:2031-5.
5. Tajima K, Tominaga S, Suchi T. Malignant lymphomas in Japan: epidemiological analysis on adult T-cell leukemia/lymphoma. Hematol Oncol 1986;4:31-44.
6. Hinuma Y, Imai J. Epstein-Barr virus-specific antibodies in patients with adult T-cell leukemia (ATL) and healthy ATL virus-carriers. Int J Cancer 1983;31:197-200.
7. Adedayo AO, Grell GAC, Bellot P. Case study: fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 2001;65:650-1.
8. Ikeda M, Fujino R, Matsui T, Yoshida T, Komoda H, Imai J. A new agglutination test for serum antibodies to adult T-cell leukemia virus. Gann 1984;75:845-8.
9. Reedman B, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973;11:499-520.
10. Heyworth MF. Parasitic diseases in immunocompromised hosts. Criptosporidiosis, isosporiasis and strongyloidiasis. Gastroenterol Clin North Am 1996;25:691-707.
11. Milder JE, Walzer PD, Kilgore G, Rutherford I, Klein M. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterol 1981;80:1481-8.
12. Kishaba T. Disseminated strongyloidiasis. In: Shiroma Y, Sato Y, editors. Strongyloides stercoralis and strongyloidiasis in Japan. Fukuoka: Kyushyu University Press; 1997. p. 55-78.
13. Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T. Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 1995;79:270-6.
14. Yamaguchi K, Kiyokawa T, Nakada K, Lee SY, Asou N, Ishii T, et al. Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL. Br J Haematol 1988;68:169-74.
15. Ono A, Ikeda E, Mochizuki M, Matsuoka M, Yamaguchi K, Sawada T, et al. Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities. Jpn J Cancer Res 1998;89:608-14.
16. Ishihara S, Okayama A, Stuver S, Horinouchi H, Shioiri S, Murai K, et al. Association of HTLV-1 antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. J Acquir Immun Defic Syndr 1994;7:199-203.